Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AstraZeneca

Stock Market Holds Gains; Chip Stock Breaks Out

The stock market held afternoon gains as a server and storage stock flashed a sell signal. Air pollution control stock broke out of a base.

Investors Business Daily

AstraZeneca Stock Nabs Brief Breakout After $1.8 Billion CinCor Buyout

AstraZeneca stock briefly broke out on Tuesday, a day after announcing its $1.8 billion plan to acquire CinCor.

Investors Business Daily

AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal

AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at $1.8 billion.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

IBD 50 Stocks To Watch: Pharmaceutical Leader AstraZeneca Retakes Latest Buy Point

Among the top stocks to watch, pharmaceutical leader AstraZeneca is retaking its latest buy point despite Tuesday's stock market weakness.

Investors Business Daily

Gradual arrival of Chinese expected, no Covid test, says Anutin

Public Health Minister Anutin Charnvirakul does not expect a sudden influx of Chinese tourists or see a need for any special arrival rules for them.

Bangkok Post

How common are severe side effects from COVID vaccines? And how are they detected?

Former federal MP Dr Kerryn Phelps has talked this week about the medical problems she and her wife had after their COVID-19 vaccinations around 18 months ago.

The Conversation

Korean jab maker scouts Asean links

SEOUL: A South Korean company is looking for a business opportunity with partners from the Association of Southeast Asian Nations (Asean) to help develop the regional market for its Covid-19 vaccine.

Bangkok Post

Read news from The Economist, FT, and more,
with one subscription

Covid vaccine concerns were overblown, says AstraZeneca boss as he is knighted

Sir Pascal Soriot was speaking after he was knighted by the King at Windsor Castle on Wednesday.

The Independent UK

AstraZeneca Stock Hits New Relative Strength Highs, Reaches Buy Zone

AstraZeneca is breaking out on the strength of its relative strength highs and as profits continue to grow.

Investors Business Daily

Scientists hail ‘landmark moment’ in the treatment of advanced breast cancer

Capivasertib is being made by pharmaceutical giant AstraZeneca following a programme of drug discovery research at the Institute of Cancer Research.

The Independent UK

‘Landmark moment’ in breast cancer treatment could save thousands of lives each year

‘The treatment is far less debilitating than chemotherapy and I’ve been given the gift of a longer life,’ says one patient

The Independent UK

The business of clinical trials is booming. Private equity has taken notice

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

Tribune News Service

Mum-of-two left in coma after Covid jab now diagnosed with rare and serious condition

Sarah Birch, 46, from Rochester, Kent, fell desperately ill after receiving her Covid vaccine last year and was in a coma for four days

Daily Mirror

Mum seeking compensation after falling into coma days after Covid jab

Sarah has been left unable to work and has been bed-bound for months

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

Birmingham Post

Shares surge in drug discovery company after $402m AstraZeneca deal announced

Shares in C4X Discovery Holdings plc have jumped since the deal was announced

Asharq Al-Awsat

AstraZeneca’s CEO on Covid: ‘We Just Have to Adjust to it’

AstraZeneca’s Chief Executive Officer, Sir Pascal Soriot, told Asharq Al-Awsat in an interview that Covid-19 is not over “and we just have to adjust to it like we live with the flu.” “Most people who get it basically get sick for a few days and do not need to be…

Investors Business Daily

AstraZeneca Makes A Break For A Buy Point On Massive Third-Quarter Growth

AstraZeneca leaned on cancer drugs in the third-quarter, leading to double-digit sales growth, a strong beat and a jump for AZN stock.

Benzinga

Troubled FTX Faces SEC Probe And 'Urgently Needs' $8B To Avoid Bankruptcy, NIO Posts Wider Q3 Loss, AstraZeneca Ditches US Application Submission For COVID-19 Shot: Top Stories Thursday, Nov. 11

Bloomberg

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Surges 900 Points On Cool Inflation Data; Treasury Yields Dive

The Dow Jones Industrial Average surged 900 points Thursday on cool inflation data, with the consumer price index (CPI) coming in lower than expected.

The Independent UK

AstraZeneca drops plans for Covid jab approval in US

The drugs giant will instead focus its Covid-19 vaccine efforts elsewhere globally and for its use as a booster.

Bangkok Post

Expert warns of winter Covid surge

A Chulalongkorn University virologist has warned about a potential surge in Covid-19 cases during the cold season that will likely peak in January.

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

Benzinga

Tesla Shifts China Factory Workers To US Plant, Complete European Approval For AstraZeneca's COVID-19 Shot, Tesla Eyes Cybertruck Commercialization Next Year: Top Stories Tuesday, Nov. 1

Bloomberg Tesla Migrates Shanghai Factory Workers To Boost US Plant Production

Benzinga

Intel's Self-Driving Tech Firm Raises Over $800M In IPO, Alphabet Misses Q3 Earnings Expectations, Lyft Cuts Price For Monthly Subscription Plan: Top Stories Wednesday, Oct. 26

Benzinga

Asharq Al-Awsat

High Hopes for Nasal Covid Vaccines despite 'Disappointing' Trial

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite "disappointing" recent trial results for an AstraZeneca spray, experts say. By entering the body the same way as the virus, nasal vaccines aim to build immunity in the mucous membrane that lines the nose and…

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.